Latest filing published 18 Aug 2026 for Keros Therapeutics, Inc., €4,936.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Newton Charles W.: trading record in brief
All filings by Newton Charles W. on record concern Keros Therapeutics, Inc. The record holds 2 filings, for trades running from 11 June 2026 to 18 August 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 18 August 2026 came the latest disclosure, a transaction for €4,936 in Keros Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Newton Charles W.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 551 shares@ US$10.38CommonSEC144:0001969223-26-000924
- 550 shares@ US$9.950.0024% mcap100.0% of flowCommonSEC144:0001969223-26-000680
2 of 2 declarations
